Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 72 Genitourinary 56 Plasma cell 29 Sarcoma 16 Thoracic 15 CNS 7 Gastrointestinal 6 Other hematologic neoplasm 5 Lymphoid 5 Gynecologic 5 Tumor-Agnostic 4 Myeloid 2 Other solid neoplasm 1 Other neoplasm 1 Head & Neck 1

Conditions

Interventions

Cisplatin 145 pembrolizumab 129 Carboplatin 125 Injections 108 Pemetrexed 97 Paclitaxel 97 Gemcitabine 85 Irinotecan 75 Nivolumab 71 Cyclophosphamide 71 Docetaxel 68 Bevacizumab 57 Oxaliplatin 49 Fluorouracil 48 atezolizumab 46 Capecitabine 46 Etoposide 42 Leucovorin 41 tislelizumab 40 toripalimab 36 fludarabine 32 Ipilimumab 30 Drug Therapy 30 Topotecan 29 durvalumab 28 Vincristine 27 Early Intervention, Educational 27 Radiotherapy 26 Interviews as Topic 26 Specimen Handling 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Zoledronic Acid × Other solid neoplasm × Clear all

NCT01204203 2017-05-24

UAB0901

University of Alabama at Birmingham

Phase 2 Completed

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡